Affinity DataKd: 6.64E+3nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 2.48E+3nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 4.38E+3nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 4.40E+3nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 5.37E+5nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 1.04E+4nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
Affinity DataKd: 1.99E+4nMAssay Description:(1) Screening of Macrolide and Cyclic Peptide Drugs by Taking SelH as a TargetA surface plasmon resonance (SPR) method was adopted to detect the inte...More data for this Ligand-Target Pair
